Central Nervous System
Research from Royal National Orthopaedic Hospital in the area of central nervous system published
Published in Cancer Weekly, December 14th, 2010
2010 DEC 14 -- A new study, 'A 20-year follow-up of the mesh wallstent in the treatment of detrusor external sphincter dyssynergia in patients with spinal cord injury,' is now available. "To assess the long-term (20 years) effectiveness of the UroLume wallstent™ (Pfizer Inc., UK) in the treatment of detrusor external sphincter dyssynergia (DESD) in patients with spinal cord injury (SCI). Twelve patients with quadriplegia secondary to SCI underwent external striated sphincter stenting with the UroLume wallstent in place of sphincterotomy for DESD ˜ 20 years ago," scientists in Stanmore, the United Kingdom report.
"The mean (range) age was 41.8 (26-65)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2010-12-14)
More Articles from Cancer Weekly
- Lung Cancer
Findings from Fudan University in lung cancer reported - Gastric Cancer
Findings from Kanazawa University, Division of Cancer Medicine advance knowledge in gastric cancer - Oral Cancer
Findings from University of Bari provide new insights into oral cancer - Prostate Cancer
Investigators at Keio University, Department of Urology zero in on prostate cancer - Gastric Cancer
Investigators at Shanghai Jiao Tong University publish new data on gastric cancer - Bladder Cancer
New bladder cancer research from Memorial Sloan-Kettering Cancer Center, Department of Urology discussed - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
